About Hokkaido Region Facility
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hokkaido Region Facility
During the past decade, Hokkaido Region Facility conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
2019-07-30
2021-02-15
Completed
1,879
Benefits of Microcor in Ambulatory Decompensated Heart Failure
2019-11-01
2023-06-30
Active, not recruiting
266
A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
2020-07-01
2021-10-08
Completed
278
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
2020-10-19
2022-11-01
Completed
1,428
A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure
2021-03-04
2022-09-20
Completed
160
A Study of LY3437943 in Participants With Type 2 Diabetes
2021-05-13
2022-10-27
Completed
281
Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease
2021-08-31
2022-07-30
Recruiting
24
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hokkaido Region Facility"
#1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hokkaido Region Facility
According to Clinical.Site data, the most researched conditions in "Hokkaido Region Facility" are
"Acute Lung Injury" (1 trials), "Involutional Osteoporosis" (1 trials), "Malignant Tumor" (1 trials), "Stroke" (1 trials) and "Systemic Inflammatory Response Syndrome" (1 trials). Many other conditions were trialed in "Hokkaido Region Facility" in a lesser frequency.
Clinical Trials Intervention Types at Hokkaido Region Facility
Most popular intervention types in "Hokkaido Region Facility" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Minodronic acid hydrate" (1 trials), "ONO-2506" (1 trials), "ONO-7436" (1 trials) and "Sivelestat sodium hydrate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hokkaido Region Facility
The vast majority of trials in "Hokkaido Region Facility" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hokkaido Region Facility
Currently, there are NaN active trials in "Hokkaido Region Facility".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hokkaido Region Facility,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hokkaido Region Facility, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".